Marco Sanduzzi-Zamparelli

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Systematic Review

Machine Learning

Metastatic Colorectal Cancer

Top Venues

United European gastroenterology journal

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Fortuny, Marco Sanduzzi-Zamparelli, Maria Reig
Systemic therapies in hepatocellular carcinoma: A revolution? United European gastroenterology journal 12 (2) (2024)
Marta Fortuny, Marco Sanduzzi-Zamparelli, Maria Reig
Systemic therapies in hepatocellular carcinoma: A revolution? United European gastroenterology journal 12 (2) (2024)
Marta Fortuny, Marco Sanduzzi-Zamparelli, Maria Reig
Systemic therapies in hepatocellular carcinoma: A revolution? United European gastroenterology journal 12 (2) (2024)
Marta Fortuny, Marco Sanduzzi-Zamparelli, Maria Reig
Systemic therapies in hepatocellular carcinoma: A revolution? United European gastroenterology journal (2024)
Marta Fortuny, Marco Sanduzzi-Zamparelli, Maria Reig
Systemic therapies in hepatocellular carcinoma: A revolution? United European gastroenterology journal 12 (2) (2024)
Ismael El Hajra, Marco Sanduzzi-Zamparelli, Víctor Sapena, Sergio Muñoz-Martínez, Ezequiel Mauro, Neus Llarch, Gemma Iserte, Alejandro Forner, Jose Ríos, Jordi Bruix, Maria Reig
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis. Hepatology (Baltimore, Md.) 77 (4) (2023)
Ismael El Hajra, Marco Sanduzzi-Zamparelli, Víctor Sapena, Sergio Muñoz-Martínez, Ezequiel Mauro, Neus Llarch, Gemma Iserte, Alejandro Forner, Jose Ríos, Jordi Bruix, Maria Reig
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis. Hepatology (Baltimore, Md.) 77 (4) (2023)
Ismael El Hajra, Marco Sanduzzi-Zamparelli, Víctor Sapena, Sergio Muñoz-Martínez, Ezequiel Mauro, Neus Llarch, Gemma Iserte, Alejandro Forner, Jose Ríos, Jordi Bruix, Maria Reig
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis. Hepatology (Baltimore, Md.) 77 (4) (2023)
Sergio Muñoz-Martínez, Víctor Sapena, Alejandro Forner, Jordi Bruix, Marco Sanduzzi-Zamparelli, Jose Ríos, Mohamed Bouattour, Mohamed El Kassas, Cassia R G Leal, Tudor Mocan, Jean Charles Nault, Rogerio C P Alves, Helen L Reeves, Leonardo Gomes da Fonseca, Ignacio García-Juárez, David James Pinato, Maria Varela, Saleh A Alqahthani, Mário Reis Alvares-DA-Silva, Juan C Bandi, Lorenza Rimassa, Mar Lozano, Jesús M González-Santiago, Frank Tacke, Margarita Sala, María Anders, Anja Lachenmayer, Federico Piñero, Alex França, Maria Guarino, Alessandra Elvevi, Giuseppe Cabibbo, Markus Peck-Radosavljevic, Ángela Rojas, Mercedes Vergara, Chiara Braconi, Sonia Pascual-Bartolomé, Christie Perelló, Vivianne Mello, Carlos Rodríguez-Lope, Juan Acevedo, Rosanna Villani, Clemence Hollande, Valérie Vilgrain, Ahmed Tawheed, Carmem Ferguson Theodoro, Zeno Sparchez, Lorraine Blaise, Daniele E Viera-Alves, Robyn Watson, Flair J Carrilho, Carlos Moctezuma-Velazquez, Antonio D'Alessio, Massimo Iavarone, Maria Reig
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study. Liver international : official journal of the International Association for the Study of the Liver 42 (8) (2022)
Álvaro Díaz-González, Víctor Sapena, Loreto Boix, Ferràn Torres, Marco Sanduzzi-Zamparelli, Leonardo Gomes da Fonseca, Neus Llarch, Gemma Iserte, Cassia Guedes, Sergio Muñoz-Martínez, Anna Darnell, Ernest Belmonte, Jordi Rimola, Alejandro Forner, Carmen Ayuso, Jordi Bruix, Maria Reig
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs. United European gastroenterology journal 9 (6) (2021)
Marco Sanduzzi-Zamparelli, Víctor Sapena, Jordi Bruix, Maria Reig
Letter: are sorafenib-related adverse events associated with prolonged survival? Authors' reply. Alimentary pharmacology & therapeutics 51 (1) (2020)
Álvaro Díaz-González, Víctor Sapena, Loreto Boix, Mercè Brunet, Ferràn Torres, Neus LLarch, Esther Samper, Olga Millán, Josep Corominas, Gemma Iserte, Marco Sanduzzi-Zamparelli, Leonardo Gomes da Fonseca, Anna Darnell, Ernest Belmonte, Alejandro Forner, Carmen Ayuso, Jordi Bruix, Maria Reig
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials. Liver international : official journal of the International Association for the Study of the Liver 40 (10) (2020)
Álvaro Díaz-González, Marco Sanduzzi-Zamparelli, Leonardo Gomes da Fonseca, Giovan G Di Costanzo, Rogerio Alves, Massimo Iavarone, Cassia Leal, Rodolfo Sacco, Ana M Matilla, Manuel Hernández Guerra, Gabriel Aballay Soteras, Marcus-Alexander Wörns, Matthias Pinter, Maria Varela, Morten Ladekarl, Aline Lopes Chagas, Beatriz Mínguez, Juan I Arenas, Alessandro Granito, Yolanda Sánchez-Torrijos, Ángela Rojas, Carlos Rodríguez de Lope, Mario R Alvares-da-Silva, Sonia Pascual, Lorenza Rimassa, José L Lledó, Carlos Huertas, Bruno Sangro, Edoardo Giovanni Giannini, Manuel Delgado, Mercedes Vergara, Christie Perelló, Alberto Lue, Margarita Sala, Adolfo Gallego, Susanna Coll, Tania Hernáez, Federico Piñero, Gustavo Henrique Santos Pereira, Alex França, Juan Marín, Margarita Anders, Vivianne Mello, Mar Lozano, Jean Charles Nault, Josemaría Menéndez, Ignacio García Juárez, Jordi Bruix, Maria Reig
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis. Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Álvaro Díaz-González, Marco Sanduzzi-Zamparelli, Víctor Sapena, Ferràn Torres, Neus Llarch, Gemma Iserte, Alejandro Forner, Leonardo Gomes da Fonseca, Jose Ríos, Jordi Bruix, Maria Reig
Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib. Alimentary pharmacology & therapeutics 49 (5) (2019)